MicroRNAs as biomarkers for myocardial infarction.

Link to article at PubMed

Related Articles

MicroRNAs as biomarkers for myocardial infarction.

Curr Atheroscler Rep. 2012 Jun;14(3):193-200

Authors: Salic K, De Windt LJ


MicroRNAs (miRs) are short non-coding RNA molecules involved in post-transcriptional gene regulation by binding to the 3' untranslated region of a messenger RNA (mRNA), thereby inhibiting the translation or inducing mRNA destabilization. MiRs are generally considered to act as intracellular mediators essential for normal cardiac function, and their deregulated expression profiles have been associated with cardiovascular diseases. Recent studies have revealed the existence of freely circulating miRs in human peripheral blood, which are present in a stable nature. This has raised the possibility that miRs may be released in the circulation and can serve as novel diagnostic markers for acute or chronic human disorders, including myocardial infarction (MI). This review summarizes the recent findings of miRs that fulfill the criteria of candidate biomarkers for MI.

PMID: 22392328 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *